TGFBR2 and breast carcinoma: To this end, we activated MET and TGFβ signaling pathways with HGF and TGFβ1, respectively, and tested their influence on TGFBR2 or MET expression in the model cell line MCF10A as well as in basal‐like breast cancer cell lines HS578T and HCC1143.